What does Whitehawk Therapeutics, Inc. do?
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its…
What is Whitehawk Therapeutics, Inc.'s P/E and P/B ratio?
Whitehawk Therapeutics, Inc. has a P/E ratio of -2.8 and a P/B ratio of 1.00.
What is Whitehawk Therapeutics, Inc.'s debt-to-equity ratio?
Whitehawk Therapeutics, Inc. has a debt-to-equity ratio of 0.00.
How much does Whitehawk Therapeutics, Inc. owe compared with what it owns?
Whitehawk Therapeutics, Inc. owes $0.06 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Whitehawk Therapeutics, Inc.'s Positivity rank?
Whitehawk Therapeutics, Inc. is ranked #2,911 of 6,775 companies globally and #1,065 of 3,999 in United States on PositoAI, with a Positivity Score of 21,081.
Does Whitehawk Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Whitehawk Therapeutics, Inc..
Where can I read the latest news about Whitehawk Therapeutics, Inc.?
Recent headlines about Whitehawk Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Whitehawk Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Whitehawk Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.